trial
as of 2026-07-01Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
NCTId NCT00682448
at a glance
Phase 4 · Completed
Enrollment 25 (actual)
Sponsored by Rush University Medical Center
Primary completion 2011-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
25 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2007-08
Primary completion
2011-08
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Rush University Medical CenterLead Sponsor
Eli Lilly and CompanyCollaborator
Investigators
1
Jeffrey A Lieberman, M.D.Principal Investigator
Sites
1 total
Chicago, United States
Facts & assertions
4 sourced
Enrollment
25
Phase
PHASE4
Primary Completion Date
2011-08
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
company
indication
investigator